CD200 and Chronic Lymphocytic Leukemia: Biological and Clinical Relevance.

MLA

D’Arena, Giovanni, et al. “CD200 and Chronic Lymphocytic Leukemia: Biological and Clinical Relevance.” Frontiers in Oncology, vol. 10, Nov. 2020, p. 584427. EBSCOhost, https://doi.org/10.3389/fonc.2020.584427.

APA

D’Arena, G., De Feo, V., Pietrantuono, G., Seneca, E., Mansueto, G., Villani, O., La Rocca, F., D’Auria, F., Statuto, T., Valvano, L., Arruga, F., Deaglio, S., Efremov, D. G., Sgambato, A., & Laurenti, L. (2020). CD200 and Chronic Lymphocytic Leukemia: Biological and Clinical Relevance. Frontiers in Oncology, 10, 584427. https://doi.org/10.3389/fonc.2020.584427

Chicago

D’Arena, Giovanni, Vincenzo De Feo, Giuseppe Pietrantuono, Elisa Seneca, Giovanna Mansueto, Oreste Villani, Francesco La Rocca, et al. 2020. “CD200 and Chronic Lymphocytic Leukemia: Biological and Clinical Relevance.” Frontiers in Oncology 10 (November): 584427. doi:10.3389/fonc.2020.584427.